138 related articles for article (PubMed ID: 16283153)
1. [Neoadjuvant chemotherapy of breast carcinomas: what post-therapeutic (preoperative) information is provided by quantitative dynamic MRI?].
Wasser K; Klein SK; Junkermann H; Sinn HP; Darai S; Neff W; Kauczor HU; Delorme S
Radiologe; 2007 May; 47(5):421-9. PubMed ID: 16283153
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of tumor size measurement in breast cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherapy.
Wasser K; Sinn HP; Fink C; Klein SK; Junkermann H; Lüdemann HP; Zuna I; Delorme S
Eur Radiol; 2003 Jun; 13(6):1213-23. PubMed ID: 12764635
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of Contrast-Enhanced Ultrasound Compared With Magnetic Resonance Imaging in Assessing the Tumor Response After Neoadjuvant Chemotherapy for Breast Cancer.
Lee SC; Grant E; Sheth P; Garcia AA; Desai B; Ji L; Groshen S; Hwang D; Yamashita M; Hovanessian-Larsen L
J Ultrasound Med; 2017 May; 36(5):901-911. PubMed ID: 28150325
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound is at least as good as magnetic resonance imaging in predicting tumour size post-neoadjuvant chemotherapy in breast cancer.
Vriens BE; de Vries B; Lobbes MB; van Gastel SM; van den Berkmortel FW; Smilde TJ; van Warmerdam LJ; de Boer M; van Spronsen DJ; Smidt ML; Peer PG; Aarts MJ; Tjan-Heijnen VC;
Eur J Cancer; 2016 Jan; 52():67-76. PubMed ID: 26650831
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution.
Wasser K; Klein SK; Fink C; Junkermann H; Sinn HP; Zuna I; Knopp MV; Delorme S
Eur Radiol; 2003 Jan; 13(1):80-7. PubMed ID: 12541113
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging evaluation of residual tumors in breast cancer after neoadjuvant chemotherapy: surgical implications.
Zhou J; Li G; Sheng F; Qiao P; Zhang H; Xing X
Acta Radiol; 2016 May; 57(5):529-37. PubMed ID: 26231950
[TBL] [Abstract][Full Text] [Related]
7. The assessment of breast cancer response to neoadjuvant chemotherapy: comparison of magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography.
Park JS; Moon WK; Lyou CY; Cho N; Kang KW; Chung JK
Acta Radiol; 2011 Feb; 52(1):21-8. PubMed ID: 21498321
[TBL] [Abstract][Full Text] [Related]
8. Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy?
Segara D; Krop IE; Garber JE; Winer E; Harris L; Bellon JR; Birdwell R; Lester S; Lipsitz S; Iglehart JD; Golshan M
J Surg Oncol; 2007 Nov; 96(6):474-80. PubMed ID: 17640031
[TBL] [Abstract][Full Text] [Related]
9. MRI measurements of tumor size and pharmacokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy.
Yu HJ; Chen JH; Mehta RS; Nalcioglu O; Su MY
J Magn Reson Imaging; 2007 Sep; 26(3):615-23. PubMed ID: 17729334
[TBL] [Abstract][Full Text] [Related]
10. Comparative accuracy of preoperative tumor size assessment on mammography, sonography, and MRI: Is the accuracy affected by breast density or cancer subtype?
Leddy R; Irshad A; Metcalfe A; Mabalam P; Abid A; Ackerman S; Lewis M
J Clin Ultrasound; 2016 Jan; 44(1):17-25. PubMed ID: 26294391
[TBL] [Abstract][Full Text] [Related]
11. Prospective trial of breast MRI versus 2D and 3D ultrasound for evaluation of response to neoadjuvant chemotherapy.
Lee MC; Gonzalez SJ; Lin H; Zhao X; Kiluk JV; Laronga C; Mooney B
Ann Surg Oncol; 2015 Sep; 22(9):2888-94. PubMed ID: 25589151
[TBL] [Abstract][Full Text] [Related]
12. Computer-aided detection applied to breast MRI: assessment of CAD-generated enhancement and tumor sizes in breast cancers before and after neoadjuvant chemotherapy.
Demartini WB; Lehman CD; Peacock S; Russell MT
Acad Radiol; 2005 Jul; 12(7):806-14. PubMed ID: 16039534
[TBL] [Abstract][Full Text] [Related]
13. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer.
Ah-See ML; Makris A; Taylor NJ; Harrison M; Richman PI; Burcombe RJ; Stirling JJ; d'Arcy JA; Collins DJ; Pittam MR; Ravichandran D; Padhani AR
Clin Cancer Res; 2008 Oct; 14(20):6580-9. PubMed ID: 18927299
[TBL] [Abstract][Full Text] [Related]
14. [Value of dynamic contrast-enhanced MRI in assessment of early response to neoadjuvant chemotherapy in breast cancer].
Wang XH; Peng WJ; Xin C; Tan HN; Gu YJ; Tang F; Mao J
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):539-43. PubMed ID: 21029700
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging patterns of tumor regression after neoadjuvant chemotherapy in breast cancer patients: correlation with pathological response grading system based on tumor cellularity.
Kim TH; Kang DK; Yim H; Jung YS; Kim KS; Kang SY
J Comput Assist Tomogr; 2012; 36(2):200-6. PubMed ID: 22446360
[TBL] [Abstract][Full Text] [Related]
16. [O-Twist Marker for marking breast cancer under neoadjuvant chemotherapy--first results].
Viehweg P; Fabel K; Petzold A; Friedrich K; Laniado M
Rofo; 2007 Oct; 179(10):1055-60. PubMed ID: 17594630
[TBL] [Abstract][Full Text] [Related]
17. Response to neoadjuvant treatment of invasive ductal breast carcinomas including outcome evaluation: MRI analysis by an automatic CAD system in comparison to visual evaluation.
Böttcher J; Renz DM; Zahm DM; Pfeil A; Fallenberg EM; Streitparth F; Maurer MH; Hamm B; Engelken FJ
Acta Oncol; 2014 Jun; 53(6):759-68. PubMed ID: 24299492
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy.
Chagpar AB; Middleton LP; Sahin AA; Dempsey P; Buzdar AU; Mirza AN; Ames FC; Babiera GV; Feig BW; Hunt KK; Kuerer HM; Meric-Bernstam F; Ross MI; Singletary SE
Ann Surg; 2006 Feb; 243(2):257-64. PubMed ID: 16432360
[TBL] [Abstract][Full Text] [Related]
19. Role of dynamic magnetic resonance imaging in the evaluation of tumor response to preoperative concurrent radiochemotherapy for large breast cancers: a prospective phase II study.
Bollet MA; Thibault F; Bouillon K; Meunier M; Sigal-Zafrani B; Savignoni A; Diéras V; Nos C; Salmon R; Fourquet A;
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):13-8. PubMed ID: 17449193
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging enhancement features before and after neoadjuvant chemotherapy in patients with breast cancer: a predictive value for responders.
Kang DK; Kim TH; Han TS; Kim KS; Yim H
J Comput Assist Tomogr; 2013; 37(3):432-9. PubMed ID: 23674017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
